title: Contact dermatitis due to topical spironolactone.
authors.affiliation: Dermatology Department, Faculty of Medicine, University of Cadiz, University Hospital, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Fernandez-Vozmediano
authors.forename: G
authors.initials: G
authors.lastname: Gil-Tocados
authors.forename: A
authors.initials: A
authors.lastname: Manrique-Plaza
authors.forename: M A
authors.initials: MA
authors.lastname: Romero-Cabrera
authors.forename: J
authors.initials: J
authors.lastname: Picazo-Sanchez
authors.forename: I
authors.initials: I
authors.lastname: Nieto-Montesinos
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000505:Alopecia / Q000188:drug therapy; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D012536:Scalp Dermatoses / Q000139:chemically induced*; D013148:Spironolactone / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D013148:Spironolactone